Home All News Page 48

All News

Internet And Biotech Related News

Video: Mel Gibson Stem Cell Testimonial.

Fascinating Interview with Joe Rogen, Mel Gibson, and Dr. Neil Riordan, Early Pioneer and Stem Cell Expert. Joe Rogan...
Draganfly

Draganfly (DFLYF)Announces Record Revenues & Shareholder Call.

LIVE QUOTE Vancouver, BC, May 27, 2021 (GLOBE NEWSWIRE) -- Draganfly Inc. (OTCQB:...
Biotech Stock Review

Citius Pharma (CTXR) Flexes Muscle in Business Update. Remains Our Top Idea.

Added to Watch List November 2019 @$0.55. Named Our Top Idea in 2020 @$1.02.Remains Our Top Idea in 2021...

He Shoots and He Scores. Dicerna (DRNA) up 78%.

Our Second $3.00 Watch List Company Gets Acquired for Over $1 Billion. As They say "You Can't Make This **** Up."

Institutional Analyst Newsletter. April 14, 2022.

Revive Therapeutics (RVVTF) Moves a Step Closer to FDA Verdict LIVE QUOTE

13 Keys to a Successful FDA Advisory Committee Meeting (Regulatory Focus)

RAPS' Latest | 01 August 2019 | By Zachary Brousseau  When the US Food and Drug Administration (FDA) has significant...
video

Dyadic (DYAI) Announces Effectiveness of Form 10 Registration Statement and Application to NASDAQ

JUPITER, FL / ACCESSWIRE / February 13, 2019 / Dyadic International, Inc. (the "Company") (OTCQX: DYAI) today announced that the Securities and Exchange...

Owl Rock Capital Corp. II Files for Best-Efforts IPO (S&P Global)

Owl Rock Capital Corp II has filed a Form N-2 for an initial public offering of up to 150 million of its...
Lindsay Rosenwald, Biotech Stock Review

Newsworthy: Fortress Bio (FBIO) $1.73, Gets $20 Price Target!

Adding Fortress to Biotech Stock Review Watch List @ $1.73. Misunderstood by Wall Street which tends to 'over-analyze'...

Latest article

Iconic Brands (ICNB) Reports Revenues of $13.8 Million vs $4 Million. Bounces 40% Intraday.

After a Rough Six Months in the market, Nine Month Numbers Propels the Stock 40% Higher Signaling Possible Bottoming Process. ...

Adding Silo Pharma (SILO) $3.50 to Watch List.

Look What We Found! We launched the Psychedelic Stock Review a little more than a year ago and decided...

Alzheimer Drug Trials

A winner is crowned in head-to-head Alzheimer's battle between Biogen's Aduhelm and Lilly - Dec 1, 2022 Eli...